Alaska Medication Assistance Treatment (MAT) Expansion Capacity Project will address its opioid epidemic by using the most effective and FDA approved medications alongside evidence-based practices of Dual Recovery Therapy, Critical Time Intervention case management, peer support, vocational support, Trauma Informed Care, relapse prevention, motivational interviewing, cognitive-behavioral therapy among many others. The two identified communities receiving this award will be Anchorage and Juneau for not only their high Opioid Use Dependence prevalence rates but also the complete lack of MAT services in the entire Southeastern part of the state (where Juneau is located). This project expects to increase unduplicated individuals in Anchorage by approximately 60 for the first year of the project and 130-150 unduplicated individuals in years two and three. Unduplicated individuals in Juneau will be increased by approximately 45 for the first year of the project and 75-100 unduplicated individuals in years two and three. This increases Alaska's overall MAT capacity by 250 individuals. During 2009-2015, 774 drug overdose deaths were entered into the Alaska mortality database. Overall, 512 (66 percent) decedents had a prescription drug noted as the primary or a contributing cause of death. Of the 311 illicit drug overdose deaths that were recorded in the database, 128 (41 percent) noted heroin as either the primary or a contributing cause of death. Currently, Alaska only has a MAT capacity of 215 individuals in the nonprofit agency and 200 individuals in the one for profit. With upwards of 1,700 individuals with and Opioid Dependence or Abuse Disorder diagnosis seeking treatment, this leaves over 75 percent of known individuals going without MAT.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026740-01 ALASKA STATE DEPARTMENT OF HLTH-SOC SVCS JUNEAU AK TONER STACY $1,000,000

The Arizona MAT-PDOA Criminal Justice Project is a collaborative initiative between the Arizona Health Care Cost Containment System and the Regional Behavioral Health Authorities in Arizona to address the need for medication assisted treatment (MAT) to treat opioid use disorder (OUD) for individuals involved with the criminal justice system. Outcomes include an increase in individuals enrolled in MAT and integrated care services, a reduction in illicit opioid use, a reduction in the use of prescription opioids in a non-prescribed manner, and re- incarceration of individuals receiving services through this project. The project will serve individuals who have been diagnosed with OUD and have been screened for MAT-eligibility. These individuals must be participating in drug courts, probation, parole, and/or be within 4 months of release from various detention facilities in Maricopa or Pima Counties. There will be both provider and system-level education and training on the nature, application and implementation of MAT services in order to reduce stigma and promote MAT. Project goals include improving access to MAT-services for the target population by improving infrastructure and collaboration among criminal justice entities and OTPs. The project will expand infrastructure and build capacity for state, regional, and local collaborators to implement integrated behavioral health, care coordination, and recovery support team approaches and integrated strength-based treatment planning, screening and assessment for co-occurring disorders for the target population by increasing participation in MAT services. Participant outcomes will include an increase in participant abstinence from illicit and non-illicit opioid use, decrease percentage of recidivism in criminal justice involvement, and decrease tobacco use. The project will serve a total of 80 unduplicated individuals annually.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026754-01 ARIZONA HLTH CARE COST CONTAINMENT SYS PHOENIX AZ SKURKA MICHELLE $950,000

The Colorado Office of Behavioral Health (OBH) hopes to infuse new resources in areas of the state that have been buffeted by burgeoning heroin/opiate abuse by expanding medication assisted treatment services to individuals living in these regions. The proposed project, Colorado Medication Assisted Treatment Program (CMAT), will use the evidence-based Medication Assisted Treatment with Pharmaco-therapeutic services model to provide services in the following counties of focus: Denver, Boulder, Arapahoe, Adams, Jefferson, El Paso and Pueblo. These areas are identified with the highest proportions of heroin and prescription drug misuse, as evidenced by deaths, emergency room and treatment admission data. The state estimates that nearly 40,000 individuals are in need of treatment for opioid addiction. State licensed treatment provider agencies will provide MAT therapies and other treatment services in these counties. The treatment providers will be identified through the state request for proposals process. Over the course of one-year, the Colorado OBH will enroll an additional 250 individuals. The following four strategies underlie CMATs transformative capacity: 1) the initiation of CMAT services in the identified counties; 2) in collaboration with experts in the field and consumer advisors, project staff will provide training and technical assistance to the centers to adapt their services to meet the needs of the identified populations in need of treatment; 3) OBHs service delivery partners will use Government Performance and Results Act data to measure and evaluate the project's consumer recovery outcomes; 4) the MAT staff at the Colorado OBH, in collaboration with treatment providers, will begin to develop new infrastructures to serve additional populations in need of treatment services.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026756-01 COLORADO STATE DEPT OF HUMAN SERVICES DENVER CO CONDOJANI MARC $950,000

The Connecticut Department of Mental Health and Addiction Services, in partnership with four treatment providers, proposes to launch CT MATx to fill a major gap in availability of buprenorphine and naltrexone clinic based medication-assisted treatment (MAT). Over 500 persons, over the three year grant period, with opioid use disorders will be connected to MAT, recovery coaching, evidence-based practices, and other support services. One suburban and two rural areas have been identified as among those with the highest per capita rates of opioid use and overdose deaths in the state, and have little or no MAT availability: the Torrington/Winchester area in Litchfield County; the town of Windham and surrounding towns in southern Windham County; and several towns around New Britain and Bristol in central Hartford County. In order to help these communities overcome this problem, CT MATx will: (1) employ evidence-based screening and clinical assessment, and focused engagement techniques to connect opioid- dependent individuals with buprenorphine or naltrexone plus individualized recovery coaching and support; (2) provide evidence-based prescribing, high quality and assertive case management, Motivational Interviewing, Cognitive Behavioral Treatment, 12-step facilitation, peer support, and naloxone kits; and (3) develop a statewide MAT network to identify needed changes in policy and practice to address needs for sustainable, statewide access to MAT. In years 1 and 3 of the grant, we propose to convene statewide MAT conferences in an effort to continue the attack on substance use disorder stigma and other barriers to treatment and promote MAT-specific evidence based practices. CT MATx involvement is expected to lead to reduced substance use, criminal justice involvement, and HIV risk behavior; improved housing and employment outcomes; and social networks more supportive of sobriety in these and all populations.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026749-01 CONNECTICUT ST DEPT OF MH/ADDICTION SRVS HARTFORD CT SIEMBAB LAUREN $1,000,000

The Illinois Department of Human Services, Division of Alcoholism and Substance Abuse (IDHS/DASA), proposes to serve at least 300 unduplicated male and female adults through expanded and enhanced treatment services over the three years of the grant. Funds will support expansion and enhancement of: 1) outpatient methadone treatment (OMT) services for opiate- addicted persons who are residents of City of Chicago community areas; 2.) Vivitrol injection services for primary opiate offenders who are released from incarceration in the Sheridan Correctional Center and are returning to Chicago community areas; and, 3) OMT services for opiate-addicted persons who are residents of Sangamon County in central Illinois. These two targeted geographic areas were selected based on the seriousness of opiate addiction and related problems within these areas of Illinois, coupled with their relative gaps in service needs. The expanded and enhanced OMT services for opiate-addicted persons in the City of Chicago will be provided by Specialized Assistance Services, NFP and the expanded and enhanced OMT services for residents of Sangamon County will be provided by Family Guidance Centers (FGC), Inc. Illinois TASC will be responsible for providing recruitment, case management and counseling services to the returning offenders. FGC will also be responsible for provision of the expanded Vivitrol services. Each of these provider organizations is licensed and funded by IDHS/DASA for the provision of substance use disorder treatment services, and each has currently operational service sites in these targeted areas. A performance assessment plan is provided that includes administration of the GPRA tool at admission, discharge from services, and six-month follow-up.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026758-01 ILLINOIS DEPT OF HUMAN SERVICES CHICAGO IL COHEN LISA $1,000,000

The Louisiana Department of Health and Hospitals, Office of Behavioral Health (OBH) proposes to implement the Medication Assisted Treatment-Prescription Drug and Opioid Addiction (MAT-PDOA) project to expand and enhance capacity for coordinated care, MAT, wraparound services and recovery support services for individuals with opioid use disorders in the Greater New Orleans area. Funding transferred by OBH to Metropolitan Human Services District for administration will allow a network of programs in the three-parish (Orleans, St. Bernard, and Plaquemines) catchment to increase the total number of individuals receiving MAT services and integrated care, and decrease illicit substance use and behavioral health disparities among the population of focus. Funding will be used to increase treatment capacity that will support the organized delivery and coordination of medical, behavioral, social and recovery support services in order to produce better overall health outcomes for individuals who are uninsured and have multiple healthcare needs. The proposed project activities will: 1) increase wraparound and recovery support services to 50 the first year; 2) expand Methadone/Suboxone Maintenance Treatment to uninsured individuals by 100% of what is currently served; and 3) increase to approximately 250, the number of uninsured individuals with opioid use disorders receiving accessible, effective, comprehensive, coordinated/integrated care through a network of providers within the area. The MAT-PDOA project seeks to address major challenges in substance use disorder treatment within the state. Louisiana will co-join an already established community collaborative to implement the strategic framework process at the community levels in order to address the priorities of increasing the number of individuals receiving MAT services with FDA-approved pharmacotherapies for the treatment of substance use disorders.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026746-01 LOUISIANA STATE DEPARTMENT OF HEALTH BATON ROUGE LA PERRY TRACI $1,000,000

The Division of Mental Health, Developmental Disabilities, and Substance Abuse Services, of the NC Department of Health and Human Services, in collaboration with the Department of Public Safety, proposes to implement a project with the purpose to expand and enhance access to Medication-Assisted Treatment (MAT) services for individuals with opioid use disorder. North Carolina is one of the states identified as having the highest rates of primary treatment admissions for heroin and opioids based on 2007-2013 SAMHSA's Treatment Episode Data Set (TEDS). This initiative is targeted to specifically assist in addressing the state's heroin and prescription drug use epidemic among the offender population by increasing access of individuals and families to publicly supported MAT through the identification and implementation of comprehensive strategies to improve access, quality, safety, and effectiveness in intervention, treatment, and recovery services. The program will identify the priority population of selected pre-release incarcerated offenders and offenders under post-release supervision and community probation with a diagnosed opioid use disorder. The program will assess the feasibility of initiating a pre-release program or a community-based program of MAT using one of the approved opioid use disorder treatment medications, including Extended-Release Injectable Naltrexone (Vivitrol), Oral Naltrexone tablets (Revia), buprenorphine (generic brand tablet), buprenorphine/naloxone sublingual (Suboxone), and methadone (liquid or tablet). The program will also routinely incorporate the dispensing of Naloxone (Narcan) Overdose Rescue Kits to all program participants and their families, along with the provision of standard education about preventing overdoses, and responding appropriately to potential overdose emergencies involving individuals, family members, or others at risk in the community. A total of 500 individuals will be served over the duration of the project.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026757-01 NC DIV OF MH/DEVELOP DISABIL & SUB AUBSE RALEIGH NC ARSENAULT KATHERINE $948,617

The NH Department of Health and Human Services Bureau of Drug and Alcohol Services will deliver MAT Expansion services to 1400 residents within three years, in the high-risk, high need communities of Nashua and Manchester. The purpose of MAT expansion is to reduce the number of NH residents with untreated and under-treated opioid use disorders. This purpose will be met by achieving four key goals: 1) increasing the number of NH residents with OUDs receiving integrated MAT in Nashua and Manchester through health center expansion of MAT service delivery to 1400 patients by September 2019; 2) Supporting the expansion of capacity for the provision of integrated MAT services through training of MAT teams and providers, modification of electronic health records and implementation of the MAT Community of Practice to support MAT practice expansion, best practice adoption and the aggregation of lessons learned; 3) reducing opioid use among participating patients by retaining 55% of patients in integrated MAT for at least six months and evidencing 45% of participating patients reduce opioid use at six-month follow-up; and 4) developing sustainable, adequate reimbursement mechanisms for patient-centered, effective, integrated MAT service delivery by utilizing the existing Governor's Commission on Alcohol and Drug Abuse Prevention, Treatment and Recovery as an advisory group with key decision makers, implementers, and community representatives and the creation and dissemination of policy improvement recommendations re: adequate reimbursement amounts and mechanisms for sustaining integrated MAT services by October 2018 thereby facilitating the necessary changes in the current system.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026741-01 NH STATE DEPT OF HEALTH AND HUMAN SERS CONCORD NH KELLER LINDY $1,000,000

The Oklahoma Department of Mental Health and Substance Abuse Services (ODMHSAS) provides a limited number of Medication Assisted Treatment (MAT) services for individuals with Opioid Use Disorders (OUD). The OMAT Expansion Initiative proposes to build upon the capacity and infrastructure of the state's existing MAT service delivery system to expand availability to Oklahomans who are indigent and have no other pay source. The targeted regions will be ten high-risk communities based on epidemiological data regarding prescription drug and OUD. It is anticipated that the impact on enhancing access to MAT services in the high risk communities will increase the number of individuals getting access to these lifesaving services. The OMAT Expansion Initiative proposes collaborating with Community Mental Health Centers, Comprehensive Community Addiction and Recovery Centers, and Opioid Treatment Programs in the ten high-risk communities identified. ODMHSAS will utilize its effective chronic care model developed during the past two years within Health Homes (HHs). Specific objectives to be accomplished include: 1) increase the number of admissions for MAT for OUDs by 224 treatment slots per year, each year for an increase of 50% and a total of 672 individuals; 2) increasing the number of clients receiving integrated care by 50%; 3) enhance best practices for MAT by increasing treatment retention rates by 25%; increasing treatment completion rates by 25%; decreasing illicit opioid drug use by 25% and decreasing the use of prescription opioids in a non-prescribed manner by 25% at six-month follow-up; 4) reduce the stigma of MAT in key partners, especially the courts and child welfare. The infusion of additional resources and leveraging current assets will enable the OMAT Expansion Initiative to provide clinically driven, person-centered, evidence-based substance use disorder treatment focused counseling which will deliver better results that MAT alone.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026743-01 OKLAHOMA DEPT OF MENTAL HLTH/SUBS ABUSE OKLAHOMA CITY OK REID KELLIE $950,000

The OR-MAT-PDOA will expand access to integrated medication assisted treatment (MAT) to critically underserved rural areas of Oregon. The OR-MAT-PDOA will expand the number of Opioid Treatment Programs, improve access to an existing Opioid Treatment Program, and establish a robust office-based opioid treatment practice within a large Rural Health Center, with subsequent spread to other rural primary care practices. These rural communities will receive extensive clinical support through the establishment of Project ECHO at Oregon Health and Science University. Utilizing these evidence-based practices, this project provides new tools and resources to replicate integrated MAT statewide. The OR-MAT-PDOA is a collaborative effort between the Oregon Health Authority, Adapt Oregon, Bend Treatment Center, OHSU Medical Center, OHSU Scappoose, and Columbia Pacific CCO to address paucity of MAT availability in Oregon, and the rising rates of opioid- related problems in Oregon, including overdose deaths and addiction treatment admissions. The population to be served is adults with an opioid use disorder for prescription opioids or heroin in three high risk rural communities: Oregon's North Coast; Southwestern Oregon; and Central Oregon. Project goals are to: 1) increase the number of patients receiving MAT by increasing capacity in office-based and OTP settings, 2) increase the number of DATA2000-waivered physicians in Oregon actively prescribing buprenorphine, and 3) improve treatment retention and health outcomes for OR-MAT-PDOA enrollees. Objectives include, but are not limited to: 1) serve 1110 patients over a three-year period; 2) establish three new OTP's and one primary care-based MAT practice; 3) train 100 physicians to receive their DATA2000 waivers and initiate buprenorphine prescribing; 4) provide 160 clinical consultations via Project ECHO, and 5) improve physical health and mental well-being in 25% and 35% of enrollees, respectively.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026752-01 OREGON HEALTH AUTHORITY DIRECTORS OFFICE FINACIAL SERVICES SALEM OR MCILVEEN JOHN $1,000,000

The principal goal of this project is to provide rapid initiation and ongoing treatment for Opioid Use Disorder in high risk areas across the state. This project will serve approximately 2300 individuals through the creation of 6 Centers of Excellence, over a 3 year period. Year one will focus on populations coming out of incarceration and victims of opioid overdose seen in emergency settings with special emphasis on transitional youth aged 18-25. Recognizing that MAT alone is not sufficient to effectively treat OUD, this program will also provide other necessary psychosocial interventions including peer recovery supports to assist people with their recovery from OUD. Assessment, ongoing treatment and recovery supports will be provided using a unique modification to the "hub and spoke" model developed in Vermont, disseminated by SAMHSA, and utilized in other states as well. Every person seeking care for OUD will have an individualized assessment and treatment/recovery plan developed to meet their specific needs inclusive of MAT and psychosocial interventions and providing a 'whole patient' approach at sites that we have termed "Centers of Excellence for the Treatment of OUD". Specific outcomes to be measured include: 1) an increase in the number of admissions into MAT; 2) an increase in the number of clients receiving integrated care and treatment; 3) a decrease in illicit opioid use as shown by random but regular urine toxicology screens during treatment at the COEs and at 6 month follow up; and 4) a decrease in use of prescription opioids in a non-prescribed manner (i.e.: misuse or abuse of prescription opioids) as shown by random but regular urine toxicology screens during treatment at the COEs and at 6 month follow up.

Award Number Grantee Organization Name Grantee City Grantee Statesort descending Project Director Last Name Project Director First Name Award Amount
TI026761-01 RHODE ISLAND STATE DEPT MH, RETARD & HOS CRANSTON RI AMODEI BRENDA $1,000,000